Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
beQkfHrx2brYYswR